abiraterone,olaparib
astrazeneca,merck
['propel', 'gu ', 'merck', 'astrazeneca', '$azn']
astrazeneca and merck present final results of key secondary overall survival endpoint from phase iii propel trial at asco gu cancers symposium $azn 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice